- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI boosts myocardial infarction assessment
Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.
Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.
“Non–contrast-enhanced MRI alone is not sufficient for accurate diagnosis of acute MI,” said principal investigator Dr. Yoko Mikami, a radiologist at Tsu City's Mie University Hospital.
Mikami and colleagues prospectively enrolled 37 patients diagnosed with acute myocardial infarction. Patients underwent a protocol including T2-weighted and late-enhanced MRI about five days after the onset of acute myocardial infarction. The investigators found that T2 imaging accurately pinned down areas of microvascular obstruction, which strongly correlate with post-MI hemorrhagic infarction.
The findings appeared in the October issue of the American Journal of Roentgenology.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
